Ignite Creation Date:
2024-05-05 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 9:51 AM
Study NCT ID:
NCT00697632
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2008-05-14
Brief Title:
Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Sponsor:
Mirati Therapeutics Inc
Organization:
Mirati Therapeutics Inc
Organization Data
Organization:
Mirati Therapeutics Inc
Class:
INDUSTRY
Study ID:
265-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mirati Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None